Literature DB >> 25608954

Perioperative management in myasthenia gravis: republication of a systematic review and a proposal by the guideline committee of the Japanese Association for Chest Surgery 2014.

Yoshihisa Kadota1, Hirotoshi Horio, Takeshi Mori, Noriyoshi Sawabata, Taichiro Goto, Shin-ichi Yamashita, Takeshi Nagayasu, Akinori Iwasaki.   

Abstract

Thymectomy is regarded as a useful therapeutic option for myasthenia gravis (MG), though perioperative management in MG patients is largely empirical. While evidence-based medicine is limited in the perioperative management of MG patients, treatment guidelines are required as a benchmark. We selected issues faced by physicians in clinical practice in the perioperative management of extended thymectomy for MG, and examined them with a review of the literature. The present guidelines have reached the stage of consensus within the Japanese Association for Chest Surgery.

Entities:  

Mesh:

Year:  2015        PMID: 25608954     DOI: 10.1007/s11748-015-0518-y

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  133 in total

1.  The effect of combined therapy with immunoadsorption and high-dose intravenous methylprednisolone on myasthenia gravis.

Authors:  Reiko Munakata; Kimiaki Utsugisawa; Yuriko Nagane; Munehisa Yamagata; Miyuki Oikawa; Daiji Obara; Hideo Tohgi
Journal:  Eur Neurol       Date:  2002       Impact factor: 1.710

2.  Prognostic factors for myasthenia gravis treated by thymectomy: review of 61 cases.

Authors:  I P Nieto; J P Robledo; M C Pajuelo; J A Montes; J G Giron; J G Alonso; L G Sancho
Journal:  Ann Thorac Surg       Date:  1999-06       Impact factor: 4.330

3.  High-dose intravenous immunoglobulin in the management of myasthenia gravis.

Authors:  E L Arsura; A Bick; N G Brunner; T Namba; D Grob
Journal:  Arch Intern Med       Date:  1986-07

4.  Extended thymectomy for myasthenia gravis patients: a 20-year review.

Authors:  A Masaoka; Y Yamakawa; H Niwa; I Fukai; S Kondo; M Kobayashi; Y Fujii; Y Monden
Journal:  Ann Thorac Surg       Date:  1996-09       Impact factor: 4.330

5.  Extubation after transsternal thymectomy for myasthenia gravis: a prospective analysis.

Authors:  M S Gorback; R E Moon; J M Massey
Journal:  South Med J       Date:  1991-06       Impact factor: 0.954

6.  Incidence of deep sternal wound infections after tracheostomy in cardiac surgery patients.

Authors:  Seth Daniel Force; Daniel L Miller; Rebecca Petersen; Kamal A Mansour; Joseph Craver; Robert A Guyton; Joseph I Miller
Journal:  Ann Thorac Surg       Date:  2005-08       Impact factor: 4.330

7.  Effectiveness of steroid treatment in myasthenia gravis: a retrospective study.

Authors:  V Cosi; A Citterio; M Lombardi; G Piccolo; A Romani; A Erbetta
Journal:  Acta Neurol Scand       Date:  1991-07       Impact factor: 3.209

8.  EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.

Authors:  I Elovaara; S Apostolski; P van Doorn; N E Gilhus; A Hietaharju; J Honkaniemi; I N van Schaik; N Scolding; P Soelberg Sørensen; B Udd
Journal:  Eur J Neurol       Date:  2008-09       Impact factor: 6.089

Review 9.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

10.  Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis.

Authors:  M Takamori; M Motomura; N Kawaguchi; Y Nemoto; T Hattori; H Yoshikawa; K Otsuka
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

View more
  2 in total

Review 1.  Thymectomy in Myasthenia Gravis.

Authors:  Yener Aydin; Ali Bilal Ulas; Vahit Mutlu; Abdurrahim Colak; Atilla Eroglu
Journal:  Eurasian J Med       Date:  2017-02

2.  Effectiveness and safety of thymectomy plus prednisone compares with prednisone monotherapy for the treatment of non-thymomatous Myasthenia Gravis: Protocol for a systematic review.

Authors:  Huili Yang; Dandan Liu; Xinxin Hong; Haonan Sun; Yu Zheng; Biying Yang; Wanshun Wang
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.